Semaglutide and Tirzepatide are injectable medications that belong to a class of drugs called GLP-1 receptor agonists, which mimic a hormone that regulates appetite and blood sugar. Semaglutide works by slowing digestion, reducing hunger, and promoting feelings of fullness, making it easier to eat less and stick to a healthier diet. Tirzepatide, a dual-action medication, not only enhances the effects of GLP-1 but also activates GIP (glucose-dependent insulinotropic polypeptide), offering additional benefits for blood sugar control and weight loss. These medications are administered once a week and are ideal for individuals struggling with obesity or metabolic challenges. Over time, they help reset your body’s metabolic set point, enabling sustainable weight loss.
